Search NASA⌕ Search

Engineering topics

Zhou, Yu-Feng

Publications and source records attributed to Zhou, Yu-Feng.

Constraining time dependent dark matter signals from the Sun

Dark matter (DM) particles captured by the Sun can produce high-energy electrons outside the Sun through annihilating into meta-stable mediators. The corresponding cosmic-ray electron signals observed by the space-based experiments will be time dependent due to the orbital motion of the space-based detectors. The shape of this time dependence is predictable given the orbital information of the detectors. Since the high-energy CR electron (with energy E > 100 GeV) fluxes are expected to be constant in time, non-observation of such time variation can be used to place upper limits on the DM annihilation cross section. Here we analyze the time dependence of dark matter cosmic-ray signals in three space-based experiments: AMS-02, DAMPE and CALET. Under the assumption that no time dependent signal is observed, we derive the 95% C.L. exclusion limits on the signal strength from the current data. We map our limits onto the parameter space of the dark photon model and find that the constraints are comparable with that derived from the supernova SN1987A.

79 ASTRONOMY AND ASTROPHYSICS↗

mTORC1 Promotes ARID1A Degradation and Oncogenic Chromatin Remodeling in Hepatocellular Carcinoma

Abstract The SWI/SNF chromatin remodeling complexes control accessibility of chromatin to transcriptional and coregulatory machineries. Chromatin remodeling plays important roles in normal physiology and diseases, particularly cancer. The ARID1A-containing SWI/SNF complex is commonly mutated and thought to be a key tumor suppressor in hepatocellular carcinoma (HCC), but its regulation in response to oncogenic signals remains poorly understood. mTOR is a conserved central controller of cell growth and an oncogenic driver of HCC. Remarkably, cancer mutations in mTOR and SWI/SNF complex are mutually exclusive in human HCC tumors, suggesting that they share a common oncogenic function. Here, we report that mTOR complex 1 (mTORC1) interact with ARID1A and regulates ubiquitination and proteasomal degradation of ARID1A protein. The mTORC1–ARID1A axis promoted oncogenic chromatin remodeling and YAP-dependent transcription, thereby enhancing liver cancer cell growth in vitro and tumor development in vivo. Conversely, excessive ARID1A expression counteracted AKT-driven liver tumorigenesis in vivo. Moreover, dysregulation of this axis conferred resistance to mTOR-targeted therapies. These findings demonstrate that the ARID1A–SWI/SNF complex is a regulatory target for oncogenic mTOR signaling, which is important for mTORC1-driven hepatocarcinogenesis, with implications for therapeutic interventions in HCC. Significance: mTOR promotes oncogenic chromatin remodeling by controlling ARID1A degradation, which is important for liver tumorigenesis and response to mTOR- and YAP-targeted therapies in hepatocellular carcinoma. See related commentary by Pease and Fernandez-Zapico, p. 5608

Oncology↗